# Safety Study of a Plant-based H5 Virus-Like Particles (VLP) Vaccine in Healthy Adults

> **NCT00984945** · PHASE1 · COMPLETED · sponsor: **Medicago** · enrollment: 48 (estimated)

## Conditions studied

- Virus Diseases
- RNA Virus Infections
- Respiratory Tract Diseases
- Respiratory Tract Infections

## Interventions

- **BIOLOGICAL:** H5 VLP pandemic influenza vaccine 5 µg
- **BIOLOGICAL:** H5 VLP pandemic influenza vaccine 10 µg
- **BIOLOGICAL:** H5 VLP pandemic influenza vaccine 20 µg
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT00984945
- **Lead sponsor:** Medicago
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2009-12
- **Final completion:** 2010-07
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2010-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00984945

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00984945, "Safety Study of a Plant-based H5 Virus-Like Particles (VLP) Vaccine in Healthy Adults". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT00984945. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*